Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience

Abstract Background As prognosis of patients with metastatic hepatocellular carcinoma (HCC) is mainly determined by intrahepatic HCC progression, local treatment with TACE may result in improved OS, although it is not recommended. The purpose of this study was to analyze retrospectively the efficacy...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Dominik Bettinger, Renan Spode, Nicolas Glaser, Nico Buettner, Tobias Boettler, Christoph Neumann-Haefelin, Thomas Baptist Brunner, Eleni Gkika, Lars Maruschke, Robert Thimme, Michael Schultheiss
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMC 2017-08-01
سلاسل:	BMC Gastroenterology
الموضوعات:	Hepatocellular carcinoma Metastases Sorafenib Transarterial chemoembolization Prognosis
الوصول للمادة أونلاين:	http://link.springer.com/article/10.1186/s12876-017-0656-z
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!